Liver microRNA transcriptome reveals miR-182 as link between type 2 diabetes and fatty liver disease in obesity.
Christin KrauseJan H BritsemmerMiriam BerneckerAnna MolenaarNatalie TaegeNuria Lopez-AlcantaraCathleen GeißlerMeike KaehlerKatharina IbenAnna JudyckaJonas WagnerStefan WolterOliver MannPaul PflugerIngolf CascorbiHendrik LehnertKerstin StemmerSonja C SchrieverHenriette KirchnerPublished in: eLife (2024)
This work was supported by research funding from the Deutsche Forschungsgemeinschaft (KI 1887/2-1, KI 1887/2-2, KI 1887/3-1 and CRC-TR296), the European Research Council (ERC, CoG Yoyo LepReSens no. 101002247; PTP), the Helmholtz Association (Initiative and Networking Fund International Helmholtz Research School for Diabetes; MB) and the German Center for Diabetes Research (DZD Next Grant 82DZD09D1G).
Keyphrases
- type diabetes
- glycemic control
- neoadjuvant chemotherapy
- cardiovascular disease
- insulin resistance
- cell proliferation
- long non coding rna
- weight loss
- physical activity
- mental health
- gene expression
- quality improvement
- health insurance
- metabolic syndrome
- long noncoding rna
- rna seq
- high fat diet induced
- radiation therapy
- body mass index